Stromal cell-derived factor-1α and macrophage migration-inhibitory factor induce metastatic behavior in CXCR4-expressing colon cancer cells

International Journal of Molecular Medicine

Volumn 30, Issue 6, 2012, Pages 1537-1543

  Shin, Han Na ^a   Moon, Hyun Hye ^a   Ku, Ja Lok ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Colon cancer cells; CXC chemokine receptor 4; Macrophage migration inhibitory factor; Metastasis; Stromal cell derived factor 1

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1ALPHA;

ARTICLE; CANCER CELL; CELL ADHESION; CELL COUNT; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PHASE; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; COLON METASTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL ADHESION; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL12; COLONIC NEOPLASMS; GENE EXPRESSION; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RECEPTORS, CXCR; RECEPTORS, CXCR4;

EID: 84869420406     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1141     Document Type: Article

References (45)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
2. Gupta GP and Massague J: Cancer metastasis: building a framework. Cell 127: 679-695, 2006. (Pubitemid 44781029)
3. August DA, Ottow RT and Sugarbaker PH: Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev 3: 303-324, 1984.
4. Headrick JR, Miller DL, Nagorney DM, et al: Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg 71: 975-980, 2001. (Pubitemid 32210413)
5. Welter S, Jacobs J, Krbek T, Poettgen C and Stamatis G: Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer. Eur J Cardiothorac Surg 31: 167-172, 2007. (Pubitemid 46157271)
6. Gout S and Huot J: Role of cancer microenvironment in metastasis: focus on colon cancer. Cancer Microenviron 1: 69-83, 2008.
7. Kakinuma T and Hwang ST: Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol 79: 639-651, 2006. (Pubitemid 44835596)
8. O'Hayre M, Salanga C, Handel T and Allen S: Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J 409: 635-649, 2008. (Pubitemid 351214190)
9. Balkwill F: Cancer and the chemokine network. Nat Rev Cancer 4: 540-550, 2004.
10. Kim J, Takeuchi H, Lam ST, et al: Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 23: 2744-2753, 2005. (Pubitemid 46179464)
11. Schimanski CC, Schwald S, Simiantonaki N, et al: Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res 11: 1743-1750, 2005. (Pubitemid 40471835)
12. Yoshitake N, Fukui H, Yamagishi H, et al: Expression of SDF-1α and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer. Br J Cancer 98: 1682-1689, 2008. (Pubitemid 351684689)
13. Luker KE and Luker GD: Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett 238: 30-41, 2006. (Pubitemid 44183757)
14. Kang Y, Siegel PM, Shu W, et al: A multigenic program mediating breast cancer metastasis to bone. Cancer cell 3: 537-549, 2003. (Pubitemid 36808649)
15. Smith MCP, Luker KE, Garbow JR, et al: CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 64: 8604-8612, 2004. (Pubitemid 39552073)
16. Zheng H, Fu G, Dai T and Huang H: Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 50: 274-280, 2007. (Pubitemid 47428975)
17. Busillo JM and Benovic JL: Regulation of CXCR4 signaling. Biochim Biophys Acta 1768: 952-963, 2007. (Pubitemid 46452548)
18. Wang J, Loberg R and Taichman RS: The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis. Cancer Metastasis Rev 25: 573-587, 2006. (Pubitemid 46071864)
19. Sun X, Cheng G, Hao M, et al: CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev 29: 709-722, 2010.
20. Liekens S, Schols D and Hatse S: CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization. Curr Pharm Des 16: 3903-3920, 2010.
21. Kucia M, Reca R, Miekus K, et al: Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF 1-CXCR4 axis. Stem Cells 23: 879-894, 2005. (Pubitemid 41170944)
22. Bernhagen J, Krohn R, Lue H, et al: MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13: 587-596, 2007. (Pubitemid 46828480)
23. Bach JP, Rinn B, Meyer B, Dodel R and Bacher M: Role of MIF in inflammation and tumorigenesis. Oncology 75: 127-133, 2008.
24. Mitchell RA and Bucala R: Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF). Semin Cancer Biol 10: 359-366, 2000.
25. Dessein AF, Stechly L, Jonckheere N, et al: Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells. Cancer Res 70: 4644-4654, 2010.
26. Tarnowski M, Grymula K, Liu R, et al: Human rhabdomyosarcomas secrete MIF that modulates metastatic behavior of tumor cells and inhibits recruitment of cancer-associated fibroblasts. Mol Cancer Res 8: 1328-1343, 2010.
27. Liu Z, Yang L, Xu J, Zhang X and Wang B: Enhanced expression and clinical significance of chemokine receptor CXCR2 in hepatocellular carcinoma. J Surg Res 166: 241-246, 2011.
28. Salim JP, Goette NP, Lev PR, et al: Dysregulation of stromal derived factor 1/CXCR4 axis in the megakaryocytic lineage in essential thrombocythemia. Br J Haematol 144: 69-77, 2009.
29. Zheng K, Li HY, Su XL, et al: Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells. J Exp Clin Cancer Res 29: 31, 2010.
30. Brand S, Dambacher J, Beigel F, et al: CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res 310: 117-130, 2005. (Pubitemid 41393693)
31. Wada S, Fujimoto S, Mizue Y and Nishihira J: Macrophage migration inhibitory factor in the human ovary: presence in the follicular fluids and production by granulosa cells. Biochem Mol Biol Int 41: 805-814, 1997. (Pubitemid 27182714)
32. Hemmati HD, Nakano I, Lazareff JA, et al: Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100: 15178-15183, 2003. (Pubitemid 37518036)
33. Granelli-Piperno A, Moser B, Pope M, et al: Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J Exp Med 184: 2433-2438, 1996. (Pubitemid 27023745)
34. Balkwill F: The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14: 171-179, 2004.
35. Lue H, Dewor M, Leng L, Bucala R and Bernhagen J: Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cell Signal 23: 135-144, 2011.
36. Rosenkilde MM, Gerlach LO, Jakobsen JS, Skerlj RT, Bridger GJ and Schwartz TW: Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor. J Biol Chem 279: 3033-3041, 2004.
37. Kucia M, Jankowski K, Reca R, et al: CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35: 233-245, 2004. (Pubitemid 40585309)
38. Takahashi N, Nishihira J, Sato Y, et al: Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth. Mol Med 4: 707-714, 1998. (Pubitemid 29051376)
39. He XX, Chen K, Yang J, et al: Macrophage migration inhibitory factor promotes colorectal cancer. Mol Med 15: 1-10, 2009.
40. Chambers AF, Groom AC and MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572, 2002. (Pubitemid 37328923)
41. Schwartz GK and Shah MA: Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol 23: 9408-9421, 2005.
42. Lataillade JJ, Clay D, Dupuy C, et al: Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood 95: 756-768, 2000. (Pubitemid 30062693)
43. Marchesi F, Monti P, Leone BE, et al: Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res 64: 8420-8427, 2004. (Pubitemid 39491782)
44. Lue H, Thiele M, Franz J, et al: Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 26: 5046-5059, 2007. (Pubitemid 47206949)
45. Shen X, Wang S, Wang H, Liang M, Xiao L and Wang Z: The role of SDF-1/CXCR4 axis in ovarian cancer metastasis. J Huazhong Univ Sci Technolog Med Sci 29: 363-367, 2009.